Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference

Barcelona, Spain, 5 – 8 December 2009

Thomas Kung Applied Cachexia Research, Charité Medical School, Department of Cardiology, Campus Virchow-Klinikum, Augustenburger Platz 1, D - 13353 Berlin, Germany +49 30 450 553 506; +49 30 450 553 951; [email protected]

Jochen Springer Applied Cachexia Research, Charité Medical School, Department of Cardiology, Campus Virchow-Klinikum, Augustenburger Platz 1, D - 13353 Berlin, Germany +49 30 450 553 506; +49 30 450 553 951; [email protected]; Center for Cardiovascular Research (CCR), Charité Medical School, Campus Mitte, Berlin, Germany

, PhD,

Wolfram Doehner Applied Cachexia Research, Charité Medical School, Department of Cardiology, Campus Virchow-Klinikum, Augustenburger Platz 1, D - 13353 Berlin, Germany +49 30 450 553 506; +49 30 450 553 951; [email protected]; Center for Stroke Research Berlin, Charité Medical School, Berlin, Germany

, MD PhD,

Stefan D Anker Applied Cachexia Research, Charité Medical School, Department of Cardiology, Campus Virchow-Klinikum, Augustenburger Platz 1, D - 13353 Berlin, Germany +49 30 450 553 506; +49 30 450 553 951; [email protected]; Centre for Clinical and Basic Research, IRCCS San Raffaele, Rome, Italy

, MD PhD &

Stephan von Haehling Applied Cachexia Research, Charité Medical School, Department of Cardiology, Campus Virchow-Klinikum, Augustenburger Platz 1, D - 13353 Berlin, Germany +49 30 450 553 506; +49 30 450 553 951; [email protected]; Center for Cardiovascular Research (CCR), Charité Medical School, Campus Mitte, Berlin, Germany

, MD

Abstract

Cachexia is an illness that may occur in terminal stages of many chronic illnesses including cancer, chronic heart failure, chronic renal failure or chronic obstructive pulmonary disease. Effective treatments are urgently needed in order to improve the patients' quality of life and their survival. We report highlights from the 5th Cachexia Conference held in December 2009 in Barcelona, Spain. Novel therapeutic approaches shown here include melanocortin-4 receptor antagonists, myostatin inhibition, β-blockers, IL-6 antagonism synthetic ghrelin and vitamin D.

Keywords::

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference

Barcelona, Spain, 5 – 8 December 2009

Information for

Open access

Opportunities

Help and information

Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference

Barcelona, Spain, 5 – 8 December 2009

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature